122 related articles for article (PubMed ID: 32194788)
1. Construction and validation of an eight-gene signature with great prognostic value in bladder cancer.
Yan X; Fu X; Guo ZX; Liu XP; Liu TZ; Li S
J Cancer; 2020; 11(7):1768-1779. PubMed ID: 32194788
[TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.
Wang R; Zheng Z; Mao S; Zhang W; Liu J; Li C; Liu S; Yao X
Front Oncol; 2021; 11():632459. PubMed ID: 34268106
[TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer.
Yan X; Wu HH; Chen Z; Du GW; Bai XJ; Tuoheti K; Liu TZ
Front Oncol; 2021; 11():632387. PubMed ID: 34221960
[TBL] [Abstract][Full Text] [Related]
4. An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis.
Xiong Y; Yuan L; Xiong J; Xu H; Luo Y; Wang G; Ju L; Xiao Y; Wang X
J Cell Mol Med; 2020 Feb; 24(3):2342-2355. PubMed ID: 31883309
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of a gene signature in clear cell renal cell carcinoma.
Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Front Genet; 2020; 11():333. PubMed ID: 32391054
[TBL] [Abstract][Full Text] [Related]
7. A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients.
Wang Y; Liu X; Guan G; Zhao W; Zhuang M
Front Neurol; 2019; 10():745. PubMed ID: 31379707
[No Abstract] [Full Text] [Related]
8. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
10. Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.
Wu Y; Liu Y; He A; Guan B; He S; Zhang C; Kang Z; Gong Y; Li X; Zhou L
Front Genet; 2020; 11():992. PubMed ID: 32983230
[TBL] [Abstract][Full Text] [Related]
11. A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma.
Song C; Guo Z; Yu D; Wang Y; Wang Q; Dong Z; Hu W
Front Oncol; 2020; 10():1300. PubMed ID: 32850406
[TBL] [Abstract][Full Text] [Related]
12. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
13. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
[TBL] [Abstract][Full Text] [Related]
14. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CT-based radiomics signature and nomogram as prognostic markers in patients with laryngeal squamous cell carcinoma.
Chen L; Wang H; Zeng H; Zhang Y; Ma X
Cancer Imaging; 2020 Apr; 20(1):28. PubMed ID: 32321585
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
Wang R; Zhu H; Yang M; Zhu C
Oncol Lett; 2019 Dec; 18(6):5831-5842. PubMed ID: 31788056
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
18. Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer.
Shen C; Liu J; Wang L; Liang Z; Niu H; Wang Y
Cancer Cell Int; 2020 Nov; 20(1):538. PubMed ID: 33292266
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
20. Identification of a Glucose Metabolism-related Signature for prediction of Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Wang S; Zhang L; Yu Z; Chai K; Chen J
J Cancer; 2020; 11(17):4996-5006. PubMed ID: 32742447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
